slide-placeholder

From Genomics
to Precision Medicine

slide3c

Realizing The Potential
of the Spliceosome

slide4

We Are H3

December 5, 2016
Read More »
November 14, 2016
Read More »
November 7, 2016
Read More »
October 21, 2016
Read More »
September 12, 2016
Read More »
June 14, 2016
Read More »
June 1, 2016
Read More »
May 20, 2016
Read More »
May 11, 2016
Read More »
December 4, 2015
Read More »
November 3, 2015
Read More »
October 26, 2015
Read More »

H3 Science

Our Approach

H3 Biomedicine takes a target-centric approach to drug discovery through use of biological proof-of-concept milestones to enable project…

Learn More »

Cancer Genomics

Acquired changes of the genome of cancer cells are key in disrupting the physiological function of normal cells of the body and their transformation…

Learn More »

Pipeline

Through its deep understanding of cancer genomics and target-centric drug discovery approach, H3 has assembled a compelling…

Learn More »

Why H3 is For Me

“H3 scientists are focused on answering key research questions and validating underlying scientific fundamentals; all in the interest of developing breakthrough medicines to treat cancer. H3 is comprised of a group of passionate scientists who understand that our work may have a profound impact on patients’ lives. We strive to understand the potential for these medicines and how they may benefit cancer patients.”
Morgan Welzel O’Shea, Discovery Chemistry

Learn More
home-bottom-photo-2home-bottom-photo-4